```markdown
# 中国医药市场趋势洞察报告 第七部分：医药行业主要上市公司财务情况

## 2019年
| 公司名称 | 2019-1-1 | 2019-4-1 | 2019-7-1 | 2019-10-1 | 2019-12-31 |
| --- | --- | --- | --- | --- | 
| 华兰生物 | 73 | 44 | 69 | 111 | 3 |
| 恒瑞医药 | 68 | 38 | 33 | 7 | 20 |
| 海思科 | 92 | 28 | (11) | 45 | 28 |
| 药明康德 | 41 | 73 | 73 | 55 | 11 |
| 信达生物 | (2) | 8 | 8 | 18 | 8 |
| 药明康德 | 12 | 12 | 12 | 12 | 12 |
| 药明康德 | (5) | (5) | (5) | (5) | (5) |
| 药明康德 | 34 | 34 | 34 | 34 | 34 |

## 2018年
| 公司名称 | 2018-1-1 | 2018-4-1 | 2018-7-1 | 2018-10-1 | 2018-12-31 |
| --- | --- | --- | --- | --- | 
| 华润医药 | 4003X | 14021 | 13779 | 10992 | 10992 |
| 恒瑞医药 | 6992 | 8771 | 8596 | 6011 | 6011 |
| 海思科 | 13156 | 13505 | 13405 | 5040 | 5040 |
| 药明康德 | 4270 | 4226 | 4204 | 3811 | 3811 |
| 信达生物 | 1055 | 1022 | 1022 | 445 | 445 |
| 药明康德 | 174 | 174 | 174 | 174 | 174 |
| 药明康德 | 231 | 231 | 231 | 231 | 231 |
| 药明康德 | 6071 | 6071 | 6071 | 6071 | 6071 |

## 2017年
| 公司名称 | 2017-1-1 | 2017-4-1 | 2017-7-1 | 2017-10-1 | 2017-12-31 |
| --- | --- | --- | --- | --- | 
| 华瑞医药 | 31% | 23% | 12% | 5% | 7% |
| 恒瑞医药 | 27% | 12% | 6% | 3% | 6% |
| 海思科 | 55% | 65% | 20% | 11% | 11% |
| 药明康德 | 31% | 20% | 20% | 2% | 2% |
| 信达生物 | 16% | 16% | 16% | 25% | 25% |
| 药明康德 | 10% | 10% | 10% | 10% | 10% |
| 药明康德 | 45% | 45% | 45% | 45% | 45% |
| 药明康德 | 4% | 4% | 4% | 4% | 4% |

## 2016年
| 公司名称 | 2016-1-1 | 2016-4-1 | 2016-7-1 | 2016-10-1 | 2016-12-31 |
| --- | --- | --- | --- | --- | 
| 华济医药 | 34% | 27% | 35% | 35% | 29% |
| 恒瑞医药 | 81% | 77% | 77% | 77% | 77% |
| 海思科 | 93% | 93% | 93% | 93% | 93% |
| 药明康德 | 70% | 70% | 70% | 70% | 70% |
| 信达生物 | 80% | 80% | 80% | 80% | 80% |
| 药明康德 | 65% | 65% | 65% | 65% | 65% |
| 药明康德 | 66% | 66% | 66% | 66% | 66% |
| 药明康德 | 51% | 51% | 51% | 51% | 51% |

## 2015年
| 公司名称 | 2015-1-1 | 2015-4-1 | 2015-7-1 | 2015-10-1 | 2015-12-31 |
| --- | --- | --- | --- | --- | 
| 华泽医药 | 80% | 80% | 80% | 80% | 80 |
| 恒瑞医药 | 80% | 80% | 80% | 80% | - |
| 海思科 | 80% | 80% | 80% | 80% | - |
```